Trevi Therapeutics, Inc. (TRVI): 10-Q filed Aug 6, 2026

Form type
10-Q
Filing date
Aug 6, 2026
Accession number
0001193125-26-338023
Filer
Trevi Therapeutics, Inc. (CIK 1563880)